News
At the recent SEC meeting for endocrinology and metabolism, the expert panel reviewed the proposal along with the ...
The decision comes after evidence suggested these drugs protect the heart and kidneys as well as controlling blood sugar, ...
6d
TipRanks on MSNAstraZeneca’s Phase I Study on Balcinrenone/Dapagliflozin: Key Insights for Investors
The study tested the effects of balcinrenone/dapagliflozin, a drug combination, both in fed and fasted states, and with the addition of quinidine, a P-gp inhibitor. The purpose is to understand how ...
Today’s announcement (August 20) on draft guidelines from the UK’s National Institute for Health and Care Excellence (NICE) ...
HUNDREDS of thousands more Brits could be offered weight loss jabs on the NHS in the biggest shake up of diabetes care in a decade – as the health service prepares to ease rules around ...
GPs could face a rise in prescribing and monitoring work under draft NICE guidelines recommending earlier use of newer type 2 ...
The change from the National Institute for Health and Care Excellence will be the most significant for a decade ...
20h
inews.co.uk on MSNNHS diabetes shake-up could save 22,000 lives with earlier access to weight-loss jabs
The NHS should move away from a one-size-fits-all approach of starting everyone on the same medication, to more personalised care that aims to prevent complications like heart failure and heart ...
6d
TipRanks on MSNAstraZeneca’s Real-World Study on Dapagliflozin: Implications for Heart Failure Treatment
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results